SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-17-160887
Filing Date
2017-05-05
Accepted
2017-05-05 16:31:07
Documents
16

Document Format Files

Seq Description Document Type Size
1 FILED PURSUANT TO RULE 424(B)4 d142578d424b4.htm 424B4 1507310
2 GRAPHIC g142578g04e65.jpg GRAPHIC 135419
3 GRAPHIC g142578g06l57.jpg GRAPHIC 173371
4 GRAPHIC g142578g10y51.jpg GRAPHIC 99928
5 GRAPHIC g142578g15c64.jpg GRAPHIC 44883
6 GRAPHIC g142578g21p99.jpg GRAPHIC 91078
7 GRAPHIC g142578g21v14.jpg GRAPHIC 82516
8 GRAPHIC g142578g29c20.jpg GRAPHIC 51979
9 GRAPHIC g142578g49x55.jpg GRAPHIC 151200
10 GRAPHIC g142578g51j14.jpg GRAPHIC 45707
11 GRAPHIC g142578g56i55.jpg GRAPHIC 21609
12 GRAPHIC g142578g58g66.jpg GRAPHIC 78788
13 GRAPHIC g142578g61v53.jpg GRAPHIC 44514
14 GRAPHIC g142578g74a36.jpg GRAPHIC 58485
15 GRAPHIC g142578g80t12.jpg GRAPHIC 157523
16 GRAPHIC g142578g87e13.jpg GRAPHIC 44888
  Complete submission text file 0001193125-17-160887.txt   3266987
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-217201 | Film No.: 17818811
SIC: 2834 Pharmaceutical Preparations